Table 1. Relationship of Merlin protein expression with clinical pathologic characteristics.
Variable | No. of patients |
Merlin expression in HCC |
P value | |
---|---|---|---|---|
Low | High | |||
HCC tumour tissue | <0.001 | |||
Tumor without PVTT | 37 | 12 | 25 | |
Tumour with PVTT | 148 | 100 | 48 | |
HCC tumour tissue | 0.001 | |||
Tumour | 148 | 100 | 48 | |
Adjacent non-tumour | 29 | 10 | 19 | |
Sex | 0.169 | |||
Male | 135 | 89 | 46 | |
Female | 13 | 11 | 2 | |
Age (years) | 0.205 | |||
>50 | 62 | 39 | 23 | |
≤50 | 86 | 61 | 25 | |
Tumour size (cm) | 0.351 | |||
>5 | 120 | 79 | 41 | |
≤5 | 28 | 21 | 7 | |
HBsAg | 0.335 | |||
Positive | 129 | 89 | 40 | |
Negative | 19 | 11 | 8 | |
TNM stage | 0.427 | |||
I–II | 102 | 66 | 36 | |
III–IV | 42 | 31 | 11 | |
Distant metastasis | 0.001 | |||
Yes | 44 | 38 | 6 | |
No | 104 | 62 | 42 |
HCC, hepatocellular carcinoma. TNM, tumor node metastasis. Bold numbers indicate the statistical significance.
The Pearson χ2-test was used to analyze the relationships between the expression of Merlin and the clinicopathologic features in 148 HCC with PVTT, 37 HCC without PVTT and 29 tumour adjacent tissues. A value of P<0.05 was considered to be significant.